As of August 11, the opinions issued by ANVISA in the marketing authorization process are available on the Consultations link on the Anvisa portal ( The document called Public Opinion on Medicinal Evaluation (PPAM, in Portuguese) provides a summary of the technical evaluation, including the reason that led to the approval or disapproval of the registration of a medicine.

According to ANVISA, the essence of the consultation did not change, it was only migrated to a more modern and more agile platform. Thus, it continues to allow searching by name of the drug, active ingredient, category of the drug, type of decision, company and date. In the results, in addition to the evaluation opinion, interested parties will also be able to find information about the medications, such as registered presentations, manufacturing location, use restriction, package insert, among other information.

Additional information here